Structures published

Total: 117

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0907(3)Å b=11.5779(4)Å c=22.8104(7)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1349(3)Å b=11.6868(4)Å c=22.8660(8)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0963(2)Å b=11.5574(3)Å c=22.8612(7)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1445(3)Å b=11.7130(3)Å c=22.8862(5)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1415(4)Å b=11.7002(4)Å c=22.8837(6)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1357(3)Å b=11.6782(3)Å c=22.8834(6)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1405(3)Å b=11.6923(2)Å c=22.8838(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1280(3)Å b=11.6579(3)Å c=22.8759(5)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1311(3)Å b=11.6667(2)Å c=22.8800(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1237(2)Å b=11.6442(2)Å c=22.8738(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1158(2)Å b=11.6222(2)Å c=22.8715(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1066(2)Å b=11.5983(2)Å c=22.8627(3)Å

α=90.00° β=90.00° γ=90.00°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1070(3)Å b=11.5902(3)Å c=22.8593(6)Å

α=90.00° β=90.00° γ=90.00°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1064(3)Å b=11.5845(3)Å c=22.8569(6)Å

α=90.00° β=90.00° γ=90.00°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1048(3)Å b=11.5802(3)Å c=22.8576(6)Å

α=90.00° β=90.00° γ=90.00°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0992(4)Å b=11.5635(3)Å c=22.8525(6)Å

α=90.00° β=90.00° γ=90.00°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0972(2)Å b=11.5751(2)Å c=22.8531(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0881(3)Å b=11.5538(2)Å c=22.8478(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0823(3)Å b=11.5422(2)Å c=22.8439(3)Å

α=90.00° β=90.00° γ=90.00°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1228(4)Å b=11.6522(6)Å c=22.8488(10)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1074(3)Å b=11.6193(5)Å c=22.8456(9)Å

α=90° β=90° γ=90°

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.5040(2)Å b=8.21620(10)Å c=21.9984(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0885(6)Å b=11.5482(7)Å c=22.7898(12)Å

α=90° β=90° γ=90°

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4973(2)Å b=8.21180(10)Å c=21.9658(3)Å

α=90° β=90° γ=90°

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.5008(2)Å b=8.21410(10)Å c=21.9821(4)Å

α=90° β=90° γ=90°

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.49500(10)Å b=8.20940(10)Å c=21.9489(3)Å

α=90° β=90° γ=90°

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.49140(10)Å b=8.20690(10)Å c=21.9332(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.48840(10)Å b=8.20480(10)Å c=21.9167(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.48520(10)Å b=8.20200(10)Å c=21.9002(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.48140(10)Å b=8.19930(10)Å c=21.8844(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.47950(10)Å b=8.19740(10)Å c=21.8693(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4763(2)Å b=8.19460(10)Å c=21.8522(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.47010(10)Å b=8.18890(10)Å c=21.8216(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.47340(10)Å b=8.19210(10)Å c=21.8397(3)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.46380(10)Å b=8.18350(10)Å c=21.7953(2)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.46660(10)Å b=8.18680(10)Å c=21.8103(2)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.45970(10)Å b=8.18020(10)Å c=21.7812(2)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4902(9)Å b=8.2249(6)Å c=22.0106(14)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.45880(10)Å b=8.18000(10)Å c=21.7664(2)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4899(5)Å b=8.2086(4)Å c=21.9106(9)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4829(6)Å b=8.1938(3)Å c=21.8441(9)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4687(6)Å b=8.1829(9)Å c=21.8084(4)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=14.4393(7)Å b=8.1764(4)Å c=21.7395(13)Å

α=90.00° β=90.00° γ=90.00°

C₂₀H₁₈N₂O₅

OMalley, Ciarán Erxleben, Andrea Kellehan, Seamus McArdle, Patrick

Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660

a=10.0493(6)Å b=12.6674(11)Å c=14.6060(13)Å

α=79.358(7)° β=80.034(6)° γ=89.938(6)°

C₆₄H₄₄F₈N₄O₁₄

OMalley, Ciarán Erxleben, Andrea Kellehan, Seamus McArdle, Patrick

Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660

a=27.197(5)Å b=3.7093(4)Å c=26.924(4)Å

α=90° β=94.626(16)° γ=90°

C₃₆H₂₄F₄N₂O₆

OMalley, Ciarán Erxleben, Andrea Kellehan, Seamus McArdle, Patrick

Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660

a=3.7762(4)Å b=29.2094(16)Å c=13.5261(9)Å

α=90° β=96.309(7)° γ=90°

C₁₈H₂₀Br₂Cl₂CuN₄OS

Montagner, D.Fresch, B.Browne, K.Gandin, V.Erxleben, A.

Chemical communications (Cambridge, England) (2016) 53, 1 134-137

a=14.2258(17)Å b=12.7624(18)Å c=13.8668(13)Å

α=90° β=117.138(14)° γ=90°

C₄₂H₅₆Cl₃CoN₁₈O₁₉

Kawade, Vitthal A.Kumbhar, Avinash S.Erxleben, Andrea Pachfule, Pradip Banerjee, Rahul

CrystEngComm (2011) 13, 17 5289

a=18.870(2)Å b=18.870(2)Å c=9.7466(12)Å

α=90.00° β=90.00° γ=120.00°

C₂₁H₃₃ClN₄O₉Zn₂

Erxleben, Andrea Hermann, Jolante

Journal of the Chemical Society, Dalton Transactions (2000) 4 569

a=8.7170(10)Å b=11.2850(10)Å c=15.0570(10)Å

α=99.370(10)° β=94.00(3)° γ=104.04(3)°

C₁₃H₁₈N₂O₈Zn

Erxleben, Andrea Hermann, Jolante

Journal of the Chemical Society, Dalton Transactions (2000) 4 569

a=20.290(4)Å b=8.514(2)Å c=19.488(4)Å

α=90.00° β=108.13(3)° γ=90.00°

C₃₄H₅₁N₄O_26.5Zn₅

Erxleben, Andrea Hermann, Jolante

Journal of the Chemical Society, Dalton Transactions (2000) 4 569

a=8.192(2)Å b=11.841(2)Å c=14.520(3)Å

α=100.61(3)° β=91.98(3)° γ=102.71(3)°

C₁₉H₁₃F₂NO₃

OMalley, Ciarán Erxleben, Andrea Kellehan, Seamus McArdle, Patrick

Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660

a=3.8999(2)Å b=34.7661(18)Å c=11.4896(7)Å

α=90° β=94.404(5)° γ=90°

Lawsone-bipyridyl

2(C₁₀H₆O₃)_,C₁₀H₈N₂

Pallipurath, Anuradha Skelton, Jonathan M.Delori, Amit Duffy, Connor Erxleben, Andrea Jones, William

CrystEngComm (2015) 17, 40 7684

a=10.6360(3)Å b=4.7798(1)Å c=23.0987(9)Å

α=90.00° β=96.131(2)° γ=90.00°

Lawsone-ethylenebipyridine

C₁₂H₁₂N_22,2(C₁₀H₅O₃₁)

Pallipurath, Anuradha Skelton, Jonathan M.Delori, Amit Duffy, Connor Erxleben, Andrea Jones, William

CrystEngComm (2015) 17, 40 7684

a=3.8157(1)Å b=28.0772(7)Å c=11.2326(3)Å

α=90.00° β=96.542(2)° γ=90.00°

Lawsone-trimethylenebipyridine

C₁₃H₁₄N_2,2(C₁₀H₆O₃)

Pallipurath, Anuradha Skelton, Jonathan M.Delori, Amit Duffy, Connor Erxleben, Andrea Jones, William

CrystEngComm (2015) 17, 40 7684

a=22.5402(9)Å b=50.511(2)Å c=4.6451(2)Å

α=90.00° β=90.00° γ=90.00°

Lawsone-hydroxypyridine

C₁₅H₁₁NO₄

Pallipurath, Anuradha Skelton, Jonathan M.Delori, Amit Duffy, Connor Erxleben, Andrea Jones, William

CrystEngComm (2015) 17, 40 7684

a=13.6937(12)Å b=5.1534(3)Å c=17.5288(12)Å

α=90° β=92.329(7)° γ=90°

Trans-bis(methylamine)-bis(2-aminopyridine)-platinum(II) diperchlorate

(C₁₂H₂₂N₆Pt₂)₂(ClO₄₁)

Beck, Bettina Schneider, Alexandra Freisinger, Eva Holthenrich, Dagmar Erxleben, Andrea Albinati, Alberto Zangrando, Ennio Randaccio, Lucio Lippert, Bernhard

Dalton Transactions (2003) 12 2533

a=9.394(1)Å b=11.127(1)Å c=10.174(1)Å

α=90.00° β=98.71(1)° γ=90.00°

C₅H₁₂Cl₂N₄O₄Pt

Beck, Bettina Schneider, Alexandra Freisinger, Eva Holthenrich, Dagmar Erxleben, Andrea Albinati, Alberto Zangrando, Ennio Randaccio, Lucio Lippert, Bernhard

Dalton Transactions (2003) 12 2533

a=8.830(2)Å b=14.135(3)Å c=10.635(2)Å

α=90.00° β=113.97(3)° γ=90.00°

C₅H₁₂ClN₅O₃Pt

Beck, Bettina Schneider, Alexandra Freisinger, Eva Holthenrich, Dagmar Erxleben, Andrea Albinati, Alberto Zangrando, Ennio Randaccio, Lucio Lippert, Bernhard

Dalton Transactions (2003) 12 2533

a=11.811(2)Å b=8.233(2)Å c=11.746(2)Å

α=90.00° β=97.46(3)° γ=90.00°

C₁₂H₂₂N₈O₆Pt

Beck, Bettina Schneider, Alexandra Freisinger, Eva Holthenrich, Dagmar Erxleben, Andrea Albinati, Alberto Zangrando, Ennio Randaccio, Lucio Lippert, Bernhard

Dalton Transactions (2003) 12 2533

a=8.013(2)Å b=9.394(2)Å c=12.320(3)Å

α=90.00° β=91.27(2)° γ=90.00°

C₁₆H₄₁N₁₄O_14.5Pd₂Pt

Beck, Bettina Schneider, Alexandra Freisinger, Eva Holthenrich, Dagmar Erxleben, Andrea Albinati, Alberto Zangrando, Ennio Randaccio, Lucio Lippert, Bernhard

Dalton Transactions (2003) 12 2533

a=11.447(2)Å b=13.201(3)Å c=13.673(3)Å

α=108.51(3)° β=103.75(3)° γ=110.50(3)°

C₃₀H₁₈CoN₆O₄

Kawade, Vitthal A.Kumbhar, Anupa A.Kumbhar, Avinash S.Näther, Christian Erxleben, Andrea Sonawane, Uddhavesh B.Joshi, Rajendra R.

Dalton transactions (Cambridge, England : 2003) (2011) 40, 3 639-650

a=24.0172(13)Å b=17.3052(11)Å c=14.1228(7)Å

α=90.00° β=90.00° γ=90.00°

C₂₆H₁₆CoN₆O₄

Kawade, Vitthal A.Kumbhar, Anupa A.Kumbhar, Avinash S.Näther, Christian Erxleben, Andrea Sonawane, Uddhavesh B.Joshi, Rajendra R.

Dalton transactions (Cambridge, England : 2003) (2011) 40, 3 639-650

a=8.5253(5)Å b=18.4782(15)Å c=13.9892(8)Å

α=90.00° β=93.898(7)° γ=90.00°

C₃₀H₃₂CoN₈O₉S₂

Kawade, Vitthal A.Kumbhar, Anupa A.Kumbhar, Avinash S.Näther, Christian Erxleben, Andrea Sonawane, Uddhavesh B.Joshi, Rajendra R.

Dalton transactions (Cambridge, England : 2003) (2011) 40, 3 639-650

a=13.6859(9)Å b=13.6859(9)Å c=19.184(2)Å

α=90.00° β=90.00° γ=90.00°

C₃₄H₃₄Cl₂N₂O₈Ru

Ochocki, Justyn Kasprzak, Maria Chęcińska, Lilianna Erxleben, Andrea Zyner, Elżbieta Szmigiero, Leszek Garza-Ortiz, Ariadna Reedijk, Jan

Dalton transactions (Cambridge, England : 2003) (2010) 39, 40 9711-9718

a=22.482(4)Å b=9.126(2)Å c=18.052(4)Å

α=90.00° β=93.55(3)° γ=90.00°

Cis-dichloridobis(3-imino-2-methoxyflavanone)ruthenium(II) x 3H2O

C₃₂H₂₆Cl₂N₂O₆Ru_,3H₂O

Ochocki, Justyn Kasprzak, Maria Chęcińska, Lilianna Erxleben, Andrea Zyner, Elżbieta Szmigiero, Leszek Garza-Ortiz, Ariadna Reedijk, Jan

Dalton transactions (Cambridge, England : 2003) (2010) 39, 40 9711-9718

a=22.434(4)Å b=8.694(8)Å c=17.63(1)Å

α=90.00° β=93.56(3)° γ=90.00°

C₃₄H₄₁CuN₆O_19.5

Abosede, Olufunso O.Vyas, Nilima A.Singh, Sushma B.Kumbhar, Avinash S.Kate, Anup Kumbhar, Anupa A.Khan, Ayesha Erxleben, Andrea Smith, Peter de Kock, Carmen Hoffmann, Frank Obaleye, Joshua A.

Dalton transactions (Cambridge, England : 2003) (2016) 45, 7 3003-3012

a=10.2282(4)Å b=12.6403(7)Å c=31.3839(16)Å

α=90.00° β=90.00° γ=90.00°

Aqua-bipyridine-(6-deoxy-5-oxytetracyclinato)copper(II)-nitrate- tetrahydrate

C₃₂H₃₃CuN₅O₁₂

Abosede, Olufunso O.Vyas, Nilima A.Singh, Sushma B.Kumbhar, Avinash S.Kate, Anup Kumbhar, Anupa A.Khan, Ayesha Erxleben, Andrea Smith, Peter de Kock, Carmen Hoffmann, Frank Obaleye, Joshua A.

Dalton transactions (Cambridge, England : 2003) (2016) 45, 7 3003-3012

a=10.2571(7)Å b=12.8336(8)Å c=28.5532(19)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.0785(2)Å b=11.5265(3)Å c=22.8581(6)Å

α=90° β=90° γ=90°

Sulfamerazine

C₁₁H₁₂N₄O₂S

Anuradha R. Pallipurath Jonathan M. Skelton Mark R. Warren Naghmeh Kamali Patrick McArdle Andrea Erxleben

Molecular Pharmaceutics (2015) 12, 3735-3748

a=9.1200(3)Å b=11.6339(3)Å c=22.8697(4)Å

α=90° β=90° γ=90°

catena-Poly[[lead(II)-bis(μ-4b,5,7,7a-tetrahydro-4b,7a-epiminomethanoimino-6H-imidazo[4,5-f][1,10]phenanthroline-6,13-dione)] bis(perchlorate) dihydrate]

C₂₈H₂₀N₁₂O₄Pb_2,2(ClO₄)_,2(H₂O)

Tayade, Sakharam B.Markad, Datta Kumbhar, Avinash S.Erxleben, Andrea Chakravarty, Debamitra

Acta Crystallographica Section C (2019) 75, 8

a=15.2909(3)Å b=14.2702(3)Å c=15.4064(4)Å

α=90° β=92.174(2)° γ=90°

catena-Poly[[[aquacadmium(II)]-bis(μ-4b,5,7,7a-tetrahydro-4b,7a-epiminomethanoimino-6H-imidazo[4,5-f][1,10]phenanthroline-6,13-dione)] bis(perchlorate) dihydrate]

C₂₈H₂₂CdN₁₂O_52,2(ClO₄)_,2(H₂O)

Tayade, Sakharam B.Markad, Datta Kumbhar, Avinash S.Erxleben, Andrea Chakravarty, Debamitra

Acta Crystallographica Section C (2019) 75, 8

a=15.146(3)Å b=12.2411(11)Å c=17.6555(16)Å

α=90° β=99.104(2)° γ=90°

Methandrostenolone

C₂₀H₂₈O₂

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Acta Crystallographica Section E (2013) 69, 1 o60

a=28.317(2)Å b=9.4539(5)Å c=13.7684(10)Å

α=90.00° β=111.017(9)° γ=90.00°

Fenoxycarb

C₁₇H₁₉NO₄

Karpinska, Jolanta Kuhs, Manuel Rasmuson, Ake Erxleben, Andrea McArdle, Patrick

Acta Crystallographica Section E (2012) 68, 10 o2834-o2835

a=5.9035(3)Å b=7.5712(4)Å c=35.373(2)Å

α=85.618(5)° β=86.213(5)° γ=89.046(4)°

C₂₁H₃₂N₂O

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=19.4540(7)Å b=18.7009(8)Å c=10.8348(4)Å

α=90.00° β=90.00° γ=90.00°

C₂₃H₃₈N₂O₂

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=7.1392(5)Å b=10.9541(8)Å c=26.8891(16)Å

α=90.00° β=90.00° γ=90.00°

C₂₅H₄₀N₂O₅

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=10.3775(8)Å b=7.4347(6)Å c=15.5801(8)Å

α=90.00° β=91.895(6)° γ=90.00°

C₂₄H₄₀N₂O₂

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=24.545(1)Å b=7.2894(3)Å c=15.2500(8)Å

α=90.00° β=122.679(7)° γ=90.00°

C₂₄H₄₄N₂O₄

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=10.5093(3)Å b=7.2906(2)Å c=15.5622(5)Å

α=90.00° β=94.812(3)° γ=90.00°

C₂₁H₃₂N₂O

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=7.3164(4)Å b=21.562(2)Å c=24.0058(11)Å

α=90.00° β=90.00° γ=90.00°

C₂₁H₃₄N₂O₂

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=7.2098(5)Å b=10.4654(7)Å c=26.0313(13)Å

α=90.00° β=90.00° γ=90.00°

C₂₅H₄₂N₂O₂

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=25.321(2)Å b=7.421(2)Å c=15.393(2)Å

α=90.00° β=123.40° γ=90.00°

C₂₂H₃₇N₂O_2.5

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=7.3934(2)Å b=27.5812(6)Å c=10.5964(3)Å

α=90.00° β=109.234(3)° γ=90.00°

C_21.5H₃₂N_2.5O_1.5

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=7.5672(3)Å b=19.6475(9)Å c=26.3375(9)Å

α=90.00° β=90.00° γ=90.00°

C_23.5H_34.5N_2.5O

Karpinska, Jolanta Erxleben, Andrea McArdle, Patrick

Crystal Growth & Design (2011) 11, 7 2829

a=7.233(2)Å b=11.850(2)Å c=48.672(2)Å

α=90.00° β=90.00° γ=90.00°

C₁₄H₁₅N₃O₂

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=19.367(3)Å b=7.1978(8)Å c=19.4919(16)Å

α=90.00° β=104.881(11)° γ=90.00°

C_16.5H₁₈N₃O₆

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=11.4553(7)Å b=11.5940(8)Å c=14.6223(10)Å

α=68.150(6)° β=76.810(6)° γ=74.391(6)°

C₁₆H₁₇N₅O₂S₂

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=13.9493(9)Å b=8.3273(4)Å c=16.9440(9)Å

α=90.00° β=113.288(7)° γ=90.00°

C₂₁H₂₈N₄O₄

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=5.6600(4)Å b=18.8049(16)Å c=19.4650(13)Å

α=90.00° β=90.00° γ=90.00°

C₁₁H₁₂N₂O₄

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=8.8197(6)Å b=21.1800(12)Å c=12.3153(10)Å

α=90.00° β=93.492(7)° γ=90.00°

C₁₃H₁₃N₃O₂

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=9.5379(12)Å b=5.7387(7)Å c=12.5211(18)Å

α=90.00° β=109.146(15)° γ=90.00°

C₁₄H₁₄N₂O₃

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=7.3446(4)Å b=16.3851(10)Å c=11.1975(7)Å

α=90.00° β=105.157(6)° γ=90.00°

C₁₀H₁₂N₂O₄

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=5.5336(5)Å b=8.9229(9)Å c=10.9447(11)Å

α=87.095(8)° β=89.016(8)° γ=75.137(8)°

C₁₄H₁₃N₃O₃S

Kamali, Naghmeh Aljohani, Marwah McArdle, Patrick Erxleben, Andrea

Crystal Growth & Design (2015) 15, 8 3905

a=10.9623(8)Å b=5.8715(3)Å c=12.0212(9)Å

α=90.00° β=116.754(9)° γ=90.00°

[(C₅H₅)₂Mo{cyclo(GlyCys)}]*2H₂O

Andrea Erxleben

Inorganic Chemistry (2005) 44, 1082-1094

a=7.4570(10)Å b=10.4160(10)Å c=11.0700(10)Å

α=90.00° β=109.630(10)° γ=90.00°

C₁₃H₂₈N₁₄O₁₀Pt

Michael Roitzsch Irene B. Rother Michael Willermann Andrea Erxleben Burkhard Costisella Bernhard Lippert

Inorganic Chemistry (2002) 41, 5946-5953

a=9.8880(10)Å b=10.6270(10)Å c=12.5980(10)Å

α=83.400(10)° β=88.580(10)° γ=74.060(10)°

C₁₃H₂₆Cl₂N₁₂O₁₁Pt

Michael Roitzsch Irene B. Rother Michael Willermann Andrea Erxleben Burkhard Costisella Bernhard Lippert

Inorganic Chemistry (2002) 41, 5946-5953

a=47.399(10)Å b=8.0800(16)Å c=13.853(3)Å

α=90.00° β=98.78(3)° γ=90.00°

C₆H₁₄Ag₂N₄O₁₀

Andrea Erxleben

Inorganic Chemistry (2001) 40, 2928-2931

a=8.4550(10)Å b=25.5090(10)Å c=6.4610(10)Å

α=90.00° β=96.150(10)° γ=90.00°

C₉H_8.67AgNO_3.33

Andrea Erxleben

Inorganic Chemistry (2001) 40, 2928-2931

a=23.001(3)Å b=23.001(3)Å c=4.6490(10)Å

α=90.00° β=90.00° γ=120.00°

C₂₀H₃₀Ga₂N₄O₁₄

Fergal Coleman Michael J. Hynes Andrea Erxleben

Inorganic Chemistry (2010) 49, 6725-6733

a=8.8492(3)Å b=10.4470(4)Å c=14.0948(5)Å

α=90.00° β=90.216(2)° γ=90.00°